跳至主要内容
临床试验/NCT04589962
NCT04589962已完成不适用

SUrgical Versus PERcutaneous AXillary Artery International Registry A Physician-initiated, International, Multicentric, Retrospective, Observational, Voluntary Registry - SUPER AXA International Registry

IRCCS San Raffaele18 个研究点 分布在 10 个国家目标入组 700 人开始时间: 2020年10月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
700
试验地点
18
主要终点
optimal hemostasis

研究概览

简要总结

The purpose of the Study is to compare the outcomes of the surgical and the percutaneous approach to the upper extremity access (axillary or brachial artery) during endovascular procedures on the aortic valve, the aorta, and its side branches.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who received a surgical or percutaneous access to the axillary or brachial artery during Transcatheter Aortic Valve Implantation (TAVI), Fenestrated/Branched-Endovascular Aortic Repair (F/BEVAR), chimney-EVAR (Ch-EVAR) or visceral side branches stenting, between January 2010 and May 2020
  • Adult patients ≥18 years

排除标准

  • Introducer sheath internal diameter (ID) used < 5F or > 22F
  • Patient with previous surgical axillary access on the puncture side (Pacemaker excluded)
  • Patient with subclavian / axillary / brachial occlusive disease with stenosis greater than 50%
  • Patient with previous bypass surgery or stent placement in the vicinity of access site (ie. Axillary extracorporeal cannulation with, axillo-femoral bypass, patch (venous or synthetic repair of previous axillary access, etc)
  • Bleeding diathesis or coagulopathy
  • Patients with active systemic or cutaneous infection or inflammation
  • Patients who are pregnant or lactating
  • Patient younger than 18 years of age
  • Patients who are morbidity obese (BMI > 40 Kg/m2)

结局指标

主要结局

optimal hemostasis

时间窗: 30 days

Closure success rate of the procedure without any adjunctive procedures

vascular complications

时间窗: 30 days

freedom from major access vascular complications requiring adjunctive endovascular or open procedures

Incidence of permanent peripheral nerve injury

时间窗: 30 days

freedom from permanent peripheral nerve injury with functional compromise

stroke Incidence

时间窗: periprocedural

freedom from periprocedural stroke

Durability of vessel closure

时间窗: 30 days

freedom from secondary intervention at access site

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Bertoglio Luca

Principal Investigator

IRCCS San Raffaele

研究点 (18)

Loading locations...

相似试验